Kevin R. Sayer
President CEO and Chairman of at DexCom Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: DexCom Inc., 3 years.
DexCom Inc.
Director · Chairman, CEO & President
Chief executive roles
DexCom Inc.
· President CEO and Chairman of
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2025 | DexCom Inc. | Open-market sale | −32,498 | $70.38 | $2,287,209 |
| Mar 8, 2025 | DexCom Inc. | Grant or award | +85,490 | — | — |
| Jan 29, 2025 | DexCom Inc. | Open-market sale | −33,359 | $86.91 | $2,899,231 |
| Jan 28, 2025 | DexCom Inc. | Grant or award | +68,503 | — | — |
| Apr 8, 2024 | DexCom Inc. | Open-market sale | −27,272 | $137.96 | $3,762,445 |
| Apr 8, 2024 | DexCom Inc. | Open-market sale | −22,361 | $138.71 | $3,101,694 |
| Mar 12, 2024 | DexCom Inc. | Open-market sale | −29,675 | $134.41 | $3,988,617 |
| Mar 12, 2024 | DexCom Inc. | Open-market sale | −12,470 | $131.47 | $1,639,431 |
| Mar 12, 2024 | DexCom Inc. | Open-market sale | −14,993 | $132.43 | $1,985,523 |
| Mar 12, 2024 | DexCom Inc. | Open-market sale | −20,930 | $133.55 | $2,795,202 |
| Mar 12, 2024 | DexCom Inc. | Open-market sale | −2,939 | $134.07 | $394,032 |
| Mar 8, 2024 | DexCom Inc. | Grant or award | +51,692 | — | — |
| Jan 16, 2024 | DexCom Inc. | Open-market sale | −37,325 | $123.63 | $4,614,490 |
| Jan 12, 2024 | DexCom Inc. | Grant or award | +72,709 | — | — |
| Apr 3, 2023 | DexCom Inc. | Open-market sale | −5,995 | $113.83 | $682,411 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.